Skip to main content
. 2022 Jun 29;9(5):3188–3197. doi: 10.1002/ehf2.13876

Figure 4.

Figure 4

Complications and periprocedural outcomes after TAVR in patients with AS and CA as compared with AS alone (patients from Scully et al. 2020 and Nitsche et al. 2020 are included in Nitsche et al. 2021). AS, aortic stenosis; CA, cardiac amyloidosis; TAVR, transcatheter aortic valve replacement.